2m 2m 2m 2m 2m 2m 2m
PRECIGEN (PGEN)
NASDAQ
$5.29-$0.09 (-1.67%)
Price as of Jun 23, 2026 6:21 PM EDT- $1.9BMarket Cap
- 263.51%1-Year Change
- BiotechnologyIndustry
PRECIGEN (PGEN)
$5.29-$0.09 (-1.67%)
PGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.38 | ||
Change | +$0.56 (+11.62%) | ||
Open | $4.89 | ||
High | $5.39 | ||
Low | $4.89 | ||
Previous Close | $4.82 | ||
Volume | 8,546,937 | ||
30-Day Average Volume | 5,747,200 | ||
1-Week Change | 12.08% | ||
1-Month Change | 26.89% | ||
1-Year Change | 263.51% | ||
3-Year Change | 367.83% | ||
5-Year Change | -14.60% | ||
Fundamentals | |||
Shares Outstanding | 356.5M | ||
Total Assets | $138.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $21.8M | ||
Net Income | -$7.9M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$5.0M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $80.6M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -511 | ||
Enterprise Value/Revenue | 92 | ||
P/B | 95 | ||
P/E | -269 | ||
PEG | -4 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue